Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human TNFRSF1A Antibodies:
anti-Mouse (Murine) TNFRSF1A Antibodies:
anti-Rat (Rattus) TNFRSF1A Antibodies:
Go to our pre-filtered search.
Human Monoclonal TNFRSF1A Primary Antibody for FACS - ABIN4898906
Rebelo, Bainbridge, Amel-Kashipaz, Radford, Powell, Todd, Tighe: Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. in Arthritis and rheumatism 2006
Show all 13 Pubmed References
Human Monoclonal TNFRSF1A Primary Antibody for CyTOF, FACS - ABIN4900865
Dong, Kleinberg, Silins, Flørenes, Tropé, Risberg, Nesland, Davidson: Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma. in Cancer 2007
Show all 12 Pubmed References
Mouse (Murine) Polyclonal TNFRSF1A Primary Antibody for Agon, CyTOF - ABIN5013006
LaBue, Colburn, Green: Thyrocytes isolated from autoimmune-diseased thyroids secrete soluble tumor necrosis factor-R1 that is related to their elevated protein kinase C activity. in Thyroid : official journal of the American Thyroid Association 2004
Show all 10 Pubmed References
Human Monoclonal TNFRSF1A Primary Antibody for ELISA - ABIN2688922
Aggarwal, Gollapudi, Gupta: Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. in Journal of immunology (Baltimore, Md. : 1950) 1999
Show all 8 Pubmed References
Human Monoclonal TNFRSF1A Primary Antibody for FACS, ELISA - ABIN2688925
Brockhaus, Schoenfeld, Schlaeger, Hunziker, Lesslauer, Loetscher: Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. in Proceedings of the National Academy of Sciences of the United States of America 1990
Show all 8 Pubmed References
Human Monoclonal TNFRSF1A Primary Antibody for FACS - ABIN2688923
Browning, Dougas, Ngam-ek, Bourdon, Ehrenfels, Miatkowski, Zafari, Yampaglia, Lawton, Meier: Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. in Journal of immunology (Baltimore, Md. : 1950) 1995
Show all 5 Pubmed References
Human Polyclonal TNFRSF1A Primary Antibody for Agon, FACS - ABIN5013005
Hadjadj, Cloutier, Geoffroy, Tanguay: Stent implantation in coronary porcine arteries is associated with early activation of TNFalpha and TNFalpha receptor II expression. in Atherosclerosis 2007
Show all 5 Pubmed References
Mouse (Murine) Polyclonal TNFRSF1A Primary Antibody for Func, IA - ABIN2192161
Lucas, Garcia, Donati, Hribar, Mandriota, Giroud, Buurman, Fransen, Suter, Nunez, Pepper, Grau: Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells. in European journal of immunology 1998
Show all 3 Pubmed References
Human Polyclonal TNFRSF1A Primary Antibody for IF (p), IHC (p) - ABIN682018
Abdel-Hamid, El-Azab, Moustafa: Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model. in Naunyn-Schmiedeberg's archives of pharmacology 2017
Show all 2 Pubmed References
Human Monoclonal TNFRSF1A Primary Antibody for Func, IHC (f) - ABIN2749013
Kohrgruber, Halanek, Gröger, Winter, Rappersberger, Schmitt-Egenolf, Stingl, Maurer: Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. in Journal of immunology (Baltimore, Md. : 1950) 1999
Show all 2 Pubmed References
this study evaluated TNFR1 -609G/T polymorphisms association with RA susceptibility in a sample of Mexican patients. Our results suggest that the TNFR1 -609G/T polymorphisms are not associated with RA susceptibility in a sample of Mexican patients.
Polymorphisms in the TNFR1 gene may have an impact on the symptomatology of schizophrenia in men. rs4149577 and rs1860545 SNPs were associated with the intensity of the Positive and Negative Syndrome Scale (PANSS) excitement symptoms in men, which may contribute to the risk of violent behavior.
Polymorphism of Promoter Region of TNFRSF1A Gene is associated with Radiotherapy Induced Oral Mucositis in Head and Neck Cancer.
five single nucleotide polymorphisms in the TNFRSF1A gene are not associated with autoimmune thyroid diseases in the Chinese Han population, but rs4149570 shows a weak association with Hashimoto's thyroiditis after adjusting for gender and age.
Genotype rs767455 was associated with the susceptibility of ankylosing spondylitis(AS), G allele of rs767455 exhibited an association with the risk of developing AS. Only rs1061622 was significantly associated with long-term efficacy of etanercept. The results suggest that TNFRSF1A and TNFRSF1B (show TNFRSF1B Antibodies) polymorphisms were associated with susceptibility, severity, and the long-term therapeutic efficacy of etanercept of AS patients.
RACK1 (show GNB2L1 Antibodies) associates with MOAP-1 (show MOAP1 Antibodies) via electrostatic associations similar to those observed between MOAP-1 (show MOAP1 Antibodies)/RASSF1A (show RASSF1 Antibodies) and MOAP-1 (show MOAP1 Antibodies)/TNF-R1. These events illustrate the complex nature of MOAP-1 (show MOAP1 Antibodies) regulation and characterizes the important role of the scaffolding protein, RACK1 (show GNB2L1 Antibodies), in influencing MOAP-1 (show MOAP1 Antibodies) biology.
serum level did not decrease significantly after tonsillectomy with steroid pulse therapy in IgA (show IgA Antibodies) nephropathy
The TNFRSF1A c.625+10 G allele was associated with late response to anti-TNFalpha (show TNF Antibodies) therapy but TNFRSF1A gene SNPs is not associated with spondyloarthritis.
TNFR1 is associated longitudinally with kidney function decline but not with myocardial infarct, heart failure, or mortality risk after adjustment
One third of our childhood MS patients had a heterozygous mutation in the TNFRSF1A and/or MEFV (show MEFV Antibodies) gene. This proportion by far exceeds the number of mutations expected and was higher than in adult MS patients, suggesting that these mutations might contribute to the pathogenesis of childhood MS.
Lack of TNF-alpha (show TNF Antibodies) signaling through Tnfr1 makes the mice more susceptible to acute infection but does not alter state of latency and reactivation of HSV-1.
This study demonstrated that the TNFR1, but not TNFR2 (show TNFRSF1B Antibodies), is Required for Both Histaminergic and Non-histaminergic Itch in Mice.
p55TNFR shedding has a prominent role in Th1 (show HAND1 Antibodies) mediated protection against chronic and latent tuberculosis infection
p55TNFR-IKK2 (show IKBKB Antibodies)-Ripk3 (show RIPK3 Antibodies) signalling orchestrates arthritogenic and death responses in synovial fibroblasts
his study shows that CCR-2 (show CCR2 Antibodies)/TLR-2 triggered signaling in murine peritoneal macrophages intensifies bacterial (Staphylococcus aureus) killing by reactive oxygen species through TNF-R1
Results provide experimental data on the existence of a TNFRp55-mediated anti-inflammatory circuit in dendritic cells which might contribute to the protection against reactive arthritis during the resolution of Yersinia entercolitica infection.
TNFR1 contributes to ethanol-induced hypertension and oxidative stress in the vasculature.
TNFR2 (show TNFRSF1B Antibodies) is important for the proliferative expansion of pathogenic Teff cells
NEMO (show IKBKG Antibodies) deficiency hampered activation of IKK (show CHUK Antibodies) complex in osteoclast precursors, causing arrest of osteoclastogenesis and apoptosis. Interestingly, inhibiting apoptosis by genetic ablation of TNFr1 significantly increased cell survival, but failed to rescue osteoclastogenesis or reverse osteopetrosis (show CSF1 Antibodies).
Data indicate that IL-1RI and TNF (show TNF Antibodies)-1R contribute to regulation of stress-induced, negatively reinforced drinking perhaps through overlapping signaling events downstream of these receptors, while leaving rewarding properties of alcohol largely unaffected.
Retinal ischemia results in increased expression of TNF-alpha (show TNF Antibodies) and its receptors (TNF-R1 and TNF-R2 (show TNFRSF1B Antibodies)).
Targeted gene knockdown of TNFRSF1B (show TNFRSF1B Antibodies) in zebrafish embryos results in the induction of a caspase-8 (show CASP8 Antibodies), caspase-2 (show CASP2 Antibodies) and P53 (show TP53 Antibodies)-dependent apoptotic program in endothelial cells that bypasses caspase-3 (show CASP3 Antibodies).
These results suggest that TNF-alpha (show TNF Antibodies) sources include immune cells, as well as large and small luteal cells, and that TNF-RI and TNF-RII (show TNFRSF1B Antibodies) are present in the luteal cells of the bovine corpus luteum.
The expression and cellular localization of tumor necrosis factor-alpha (TNF (show TNF Antibodies)) and its receptors (TNFRI and TNFRII (show TNFRSF1B Antibodies)) mRNAs and proteins, were determined.
The upregulation of TNFRI mRNA expression by IFNG (show IFNG Antibodies) suggests that TNF (show TNF Antibodies) and IFNG (show IFNG Antibodies) synergistically affect the death of luteal endothelial cells resulting in acute luteolysis
TNF (show TNF Antibodies) binding induces release of AIP1 (DAB2IP (show DAB2IP Antibodies)) from TNFR1, resulting in cytoplasmic translocation and concomitant formation of an intracellular signaling complex comprised of TRADD (show TRADD Antibodies), RIP1 (show RALBP1 Antibodies), TRAF2 (show TRAF2 Antibodies), and AIPl.
The protein encoded by this gene is a member of the TNF-receptor superfamily. This protein is one of the major receptors for the tumor necrosis factor-alpha. This receptor can activate NF-kappaB, mediate apoptosis, and function as a regulator of inflammation. Antiapoptotic protein BCL2-associated athanogene 4 (BAG4/SODD) and adaptor proteins TRADD and TRAF2 have been shown to interact with this receptor, and thus play regulatory roles in the signal transduction mediated by the receptor. Germline mutations of the extracellular domains of this receptor were found to be associated with the autosomal dominant periodic fever syndrome. The impaired receptor clearance is thought to be a mechanism of the disease.
, tumor necrosis factor binding protein 1
, tumor necrosis factor receptor 1A isoform beta
, tumor necrosis factor receptor superfamily member 1A
, tumor necrosis factor receptor type 1
, tumor necrosis factor-alpha receptor
, TNF receptor alpha chain
, tumor necrosis factor receptor 1
, tumor necrosis factor receptor type I
, p55 TNF receptor
, tumor necrosis factor receptor p60
, TNF Receptor 1 (TR1)
, tumor necrosis factor type I
, tumor necrosis factor receptor superfamily, member 1A
, tumor necrosis factor receptor superfamily member 1A-like
, tumor necrosis factor (TNF superfamily, member 2)
, tumor necrosis factor alpha
, tumor necrosis factor ligand superfamily member 2
, tumour necrosis factor